Development
Zeo ScientifiX, Inc.
ZEOX
$1.96
-$0.01-0.51%
OTC PK
| 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -29.78% | -31.78% | -20.35% | 2.30% | 15.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -29.78% | -31.78% | -20.35% | 2.30% | 15.96% |
| Cost of Revenue | -32.63% | 8.86% | 33.06% | 34.03% | 37.53% |
| Gross Profit | -29.40% | -35.71% | -25.08% | -0.87% | 13.62% |
| SG&A Expenses | -26.56% | -0.66% | 29.92% | 29.65% | -16.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.85% | -0.24% | 30.06% | 27.32% | -16.40% |
| Operating Income | 24.71% | -31.78% | -91.27% | -50.77% | 30.61% |
| Income Before Tax | 22.56% | -32.27% | -84.00% | -52.62% | 29.27% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 22.56% | -32.27% | -84.00% | -52.62% | 29.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.47% | -30.43% | -81.72% | -50.62% | 30.26% |
| EBIT | 24.71% | -31.78% | -91.27% | -50.77% | 30.61% |
| EBITDA | 27.48% | -22.26% | -81.71% | -44.41% | 32.94% |
| EPS Basic | 37.06% | -2.77% | -54.58% | -34.48% | 38.33% |
| Normalized Basic EPS | 36.75% | -0.81% | -56.72% | -36.34% | 37.47% |
| EPS Diluted | 37.06% | 14.19% | -24.11% | -10.76% | 43.87% |
| Normalized Diluted EPS | 36.75% | -0.81% | -56.72% | -36.34% | 37.47% |
| Average Basic Shares Outstanding | 30.27% | 24.71% | 16.62% | 8.24% | 2.54% |
| Average Diluted Shares Outstanding | 30.27% | 24.71% | 16.62% | 8.24% | 2.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |